7,7-Dimethyl-2-(pyridin-4-yl)-3H,5H,6H,7H-imidazo[4,5-F]indol-6-one
CAS: 100510-33-6
Ref. 3D-AEA51033
5mg | 181.00 € | ||
50mg | 720.00 € |
Product Information
7,7-Dimethyl-2-(pyridin-4-yl)-3H,5H,6H,7H-imidazo[4,5-F]indol-6-one (DMPI) is a selective inhibitor of ACAT. It has been shown to be an effective drug for the treatment of cancer and bowel disease. DMPI inhibits fatty acid synthesis in cardiac muscle cells by binding to the enzyme ACAT. This leads to reduced fatty acids and increased energy production for cardiac cells. DMPI also has inhibitory properties on isolated heart cells and nitroprusside (NTP).
Chemical properties
Technical inquiry about: 3D-AEA51033 7,7-Dimethyl-2-(pyridin-4-yl)-3H,5H,6H,7H-imidazo[4,5-F]indol-6-one
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.